Barclays’ upgrade of Keurig Dr Pepper (KDP) has put fresh attention on the stock, with the brokerage pointing to improved leverage, clearer financing plans around the planned split, and reduced transaction uncertainty.

The Barclays upgrade has arrived during a period of strong momentum for Keurig Dr Pepper, with a 90 day share price return of 27.34% and a year to date share price return of 20.45%. At the same time, the 1 year total shareholder return of 5.10% and 3 year total shareholder return of 16.52% present a more moderate picture over longer horizons as investors absorb guidance reaffirmations, leadership changes linked to the planned split, and fresh financing steps.

If this kind of rerating story has your attention, it can be a good moment to broaden your watchlist and uncover 20 top founder-led companies

With Keurig Dr Pepper shares up sharply over the last quarter and the stock sitting only slightly below the average analyst price target, the key question now is whether there is still a buying opportunity or if the market is already pricing in future growth.

Most Popular Narrative: 40% Undervalued

The most followed narrative on Keurig Dr Pepper pegs fair value at $33.53 per share, only slightly above the last close at $33.40, yet its long range cash flow view implies a far larger gap between price and underlying potential.

The analysts have a consensus price target of $33.53 for Keurig Dr Pepper based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $42.0, and the most bearish reporting a price target of just $28.0.

Want to see what powers this valuation gap for Keurig Dr Pepper? Revenue expansion, margin shifts and a reset earnings multiple all sit at the center of this narrative.

Result: Fair Value of $33.53 (UNDERVALUED)

However, investors still need to weigh Keurig Dr Pepper’s weaker U.S. Coffee performance and rising tariff related cost pressures, which could challenge the current growth driven narrative.

Next Steps

With sentiment on Keurig Dr Pepper clearly divided, this is a good time to look through the data yourself and decide how the risks and rewards stack up for your portfolio by reviewing the 2 key rewards and 1 important warning sign.

Looking for more ideas beyond Keurig Dr Pepper?

If Keurig Dr Pepper has sharpened your focus, do not stop here. Use the Simply Wall St screener to spot fresh ideas before the crowd catches on.

• Target reliable cash generators by reviewing companies in the solid balance sheet and fundamentals stocks screener (48 results).
• Hunt for potential bargains that combine quality and attractive prices with the 44 high quality undervalued stocks.
• Lock in potential income streams by assessing stocks featured in the 8 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.